Key Takeaways
- NexGard Plus does not cover whipworms or mange mites – two parasites that NexGard Spectra is specifically labeled to treat.
- The difference comes down to one ingredient: NexGard Spectra uses milbemycin oxime, while NexGard Plus uses moxidectin and pyrantel – and that swap changes the parasite protection spectrum considerably for dogs at risk.
- Dogs with outdoor exposure or contact with contaminated soil face higher whipworm risk; dogs with frequent contact with other dogs face higher sarcoptic mange risk – making product selection more than a cost question.
- NexGard Plus is available in the US and Canada as a prescription-required product; NexGard Spectra is the internationally registered option, and how you access each one depends heavily on where you live.
- Keep reading to understand exactly which parasites each chew covers, why the gap matters clinically, and how to match the right product to your dog’s lifestyle.
Two monthly chews. Same beef flavor. Same core flea, tick, and heartworm protection. But one covers whipworms and mange mites – and the other doesn’t. For most dog owners, that difference goes unnoticed until there’s a problem. This breakdown makes it easy to see the gap before it matters.
NexGard Plus Has a Blind Spot: No Labeled Whipworm or Mange Coverage
NexGard Plus earns strong marks for what it does cover: fleas, five tick species, heartworm prevention, roundworms, and hookworms. That’s a solid lineup for many US dogs. But the label stops notably short on two parasites that cause real harm: whipworms and mange mites. Neither is listed as a covered indication on the NexGard Plus label. Dog owners who assume they’re fully protected may be running a gap they don’t know about. FleaTickFix lays out exactly where that gap sits and which product closes it.
What Each Chew Actually Covers
NexGard Plus: Fleas, Ticks, Heartworm, Roundworms and Hookworms Only
NexGard Plus combines three active ingredients: afoxolaner (targets fleas and ticks), moxidectin (prevents heartworm), and pyrantel (treats and controls roundworms and hookworms). It’s FDA-approved for dogs and puppies 8 weeks and older, weighing at least 4 lbs. Its tick coverage is notably broad for the US market – black-legged (deer) ticks, lone star ticks, American dog ticks, brown dog ticks, and longhorned ticks are all on the label.
What’s missing: whipworms, mange mites, lice, and flea tapeworm are not labeled indications.
NexGard Spectra: Adds Whipworms, Mange Mites and Lice
NexGard Spectra combines afoxolaner with milbemycin oxime – replacing pyrantel and moxidectin entirely with a single second active that reaches further across the parasite spectrum. The result is a wider parasite net:
- Fleas and flea allergy dermatitis
- Ticks (broad species coverage, varying by regional label)
- Heartworm prevention
- Roundworms, hookworms, and whipworms
- Sarcoptic and demodectic mange mites
- Lice (in many markets)
- Helps prevent flea tapeworm when used as directed
The trade-off: NexGard Spectra is not FDA-approved and isn’t stocked in standard US veterinary channels. Accessing it from the US typically means importing from Australia or ordering through a Canadian pharmacy.
Why the Coverage Gap Matters
Whipworms: A Serious GI Threat Often Missed
Whipworms (Trichuris vulpis) are intestinal parasites that burrow into the lining of a dog’s large intestine. Infections can cause chronic diarrhea, significant weight loss, and anemia – symptoms that are easy to misattribute to other conditions. Dogs with outdoor exposure and contact with contaminated soil carry elevated risk, particularly in rural environments. Because the symptoms are gradual and the worms are microscopic, infections often go undetected until they’re well established. A monthly chew that doesn’t cover whipworms offers no protection against this – which is exactly the blind spot in NexGard Plus.
Sarcoptic and Demodectic Mange: Two Mite Risks, One Solution
Mange comes in two distinct forms, and NexGard Spectra addresses both:
- Sarcoptic mange (caused by Sarcoptes scabiei): Highly contagious, spreads between dogs and even to humans. Causes intense itching, hair loss, and crusty skin lesions. Dogs that visit dog parks, boarding facilities, or groomers face real exposure risk through direct contact with infected animals.
- Demodectic mange (caused by Demodex canis): Typically not contagious, but linked to immune suppression – common in young dogs, rescues, or dogs on immunosuppressive medications. Causes patchy hair loss and skin inflammation.
NexGard Plus carries no labeled indication for either type. For dogs with known mange risk, that’s not a minor omission.
The Ingredient Behind Spectra’s Broader Reach
The coverage difference traces back to a key ingredient swap. NexGard Plus uses moxidectin as its second active – effective for heartworm and some intestinal worms, but not whipworms or mites. NexGard Spectra replaces that with milbemycin oxime, a macrocyclic lactone with a broader nematode reach, combined with afoxolaner’s established ectoparasite activity. Together, these two actives cover whipworms and have demonstrated efficacy against the mites responsible for both sarcoptic and demodectic mange. A clinical study on afoxolaner combined with milbemycin oxime confirmed high effectiveness against naturally acquired whipworm infections in dogs. That single formulation decision is what separates the two products’ parasite spectrums.
Which Product Fits Your Dog’s Risk Profile
When NexGard Plus Is the Right Call
NexGard Plus makes practical sense for dogs in the US where it’s the locally available, FDA-approved all-in-one option. It’s a strong fit for dogs with limited soil exposure and no history of skin mite issues – typically urban or suburban dogs. The explicit US tick species labeling (including Lyme-carrying black-legged ticks) is also a meaningful advantage for dogs in the Northeast or upper Midwest. If whipworm and mite coverage aren’t needed, the convenience of a domestic prescription route tips the balance toward Plus.
When Spectra’s Wider Spectrum Wins
NexGard Spectra is the better fit when the dog’s risk profile extends beyond the basics. That includes:
- Dogs with frequent outdoor access or exposure to contaminated soil, where whipworm risk is higher
- Dogs with active mange or known mite exposure history
- High-contact dogs that visit dog parks, kennels, or trails, where sarcoptic mange transmission is a real concern
- Dog owners outside the US, where Spectra is the standard broad-spectrum chew
Availability, Prescriptions and Price in the US
NexGard Plus: US and Canada, Prescription Required
NexGard Plus is FDA-approved and sold through US veterinary channels. Federal law classifies it as prescription-only – owners need a valid vet script to purchase it from licensed US pharmacies (including online options like Chewy’s pharmacy, California Pet Pharmacy, and Valley Vet). Some online retailers advertise it without requiring a prescription upload, but that sits outside standard regulated veterinary channels. Pricing at US pharmacies typically runs in the mid-to-high $30s per month depending on the dog’s weight and pack size, with 6-packs offering modest savings.
NexGard Spectra: Widely Available Internationally
NexGard Spectra holds EMA authorization across most of Europe, is widely available in Australia as an over-the-counter product, and is accessible in Canada through licensed prescription pharmacies. In the US, it is not FDA-approved – meaning US dog owners who want Spectra typically import it from Australian retailers (no US prescription required under Australian OTC rules) or order through Canadian mail-order pharmacies (which do require a valid vet prescription). Pricing from international suppliers tends to run significantly lower – roughly $13-$17 per month for comparable weight bands – making it approximately half to two-thirds less expensive than NexGard Plus at US retail rates.
Dogs at Risk for Whipworms or Mange Need Spectra, Not Plus
For dogs with a lifestyle or location that puts whipworms or mange mites in play, NexGard Plus simply doesn’t cover the gap – no matter how consistently it’s given. The combination of afoxolaner and milbemycin oxime in NexGard Spectra is what closes it, and veterinarians in high-prevalence regions consistently recommend Spectra for dogs with meaningful exposure risk. The right choice is about matching the product’s labeled coverage to the specific parasites a dog is actually likely to encounter. That’s a conversation worth having with a vet before the next monthly dose.
For side-by-side comparisons of parasite protection products and up-to-date sourcing guidance, FleaTickFix helps dog owners navigate flea, tick, and worm prevention with straightforward, evidence-based breakdowns.
